| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 392.35M | 188.20M | 194.15M | 143.45M | 171.75M |
| Gross Profit | 96.58M | 28.32M | 58.99M | 42.24M | 51.10M |
| EBITDA | 129.98M | 60.44M | 58.89M | 40.92M | 46.04M |
| Net Income | 19.36M | -19.91M | 7.31M | 2.98M | 13.28M |
Balance Sheet | |||||
| Total Assets | 403.08M | 350.55M | 307.12M | 251.03M | 119.16M |
| Cash, Cash Equivalents and Short-Term Investments | 61.68M | 17.87M | 72.15M | 62.59M | 19.50M |
| Total Debt | 142.47M | 155.97M | 83.09M | 66.10M | 12.52M |
| Total Liabilities | 236.60M | 222.14M | 161.12M | 115.75M | 50.62M |
| Stockholders Equity | 159.61M | 121.62M | 140.35M | 133.65M | 68.54M |
Cash Flow | |||||
| Free Cash Flow | 52.09M | -36.18M | 1.70M | -9.01M | -3.57M |
| Operating Cash Flow | 146.54M | 46.12M | 67.21M | 27.79M | 36.95M |
| Investing Cash Flow | -99.21M | -152.00M | -71.06M | -95.63M | -47.83M |
| Financing Cash Flow | -3.61M | 50.64M | 13.37M | 110.91M | 10.94M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | €105.73M | ― | -0.44% | 6.54% | -14.35% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
51 Neutral | €311.53M | -12.60 | -6.82% | ― | -31.54% | -53.98% | |
47 Neutral | €17.79M | 7.83 | -0.36% | ― | -4.48% | -105.25% | |
45 Neutral | €565.89M | -1.98 | -4.52% | ― | -11.78% | -28.61% | |
38 Underperform | €6.40M | -0.16 | -97.87% | ― | 90.92% | 24.05% | |
38 Underperform | €64.20M | -2.54 | -514.29% | ― | 63.11% | 10.97% |